The pharmacotherapy of depression.
Mood Disorders Program, Clarke Institute of Psychiatry, Toronto, Ontario, Canada.
R T
RT
Joffe
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004334:Drug Administration Schedule; D016666:Fluvoxamine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*
D000928:Antidepressive Agents; D012702:Serotonin Antagonists; D016666:Fluvoxamine